Delivery Order SPE2DB20D1050-SPE2DB25FH84J
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,422.19 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded contract utilizes firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in Conshohocken, PA 19428....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 31, 2025, for Onfil 10 mg tablets (100-count units) with a ceiling value of $11,281.66. This firm fixed-price delivery order, which represents a non-competitive set-aside contract, is scheduled for ultimate completion by August 1, 2025, with performance occurring at the awardee's Conshohocken facility. The contract was issued as a child order...
- The Defense Logistics Agency awarded a delivery order valued at $7,593.44 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg, with performance in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price contract was executed on August 19, 2025, with an ultimate completion date of August 20, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor...
- The Defense Logistics Agency awarded a delivery order valued at $9,737.35 to AmerisourceBergen Drug Corp for Onfil 10 mg tablets (100 count) on August 11, 2025, with completion scheduled for August 12, 2025. This non-set-aside contract employs firm fixed pricing under a delivery order contract type and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Onfil 10 mg tablets (100-count units) with a ceiling value of $4,414.14. This competitive, non-set-aside award reflects a firm fixed-price delivery order placed against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Onfil 10 mg tablets (100 count) with a ceiling value of $3,064.78. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of July 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Onfil 10 mg tablets (100 count) under a firm fixed price contract with a ceiling value of $9,377.00. This is a competitively awarded, non-set-aside delivery order to be completed by August 15, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child contract, this delivery order derives from AmerisourceBergen's substantial...
- This delivery order, valued at $1,841.72, was awarded on August 18, 2025, to AmerisourceBergen Drug Corp for the supply of Onfil 10 mg tablets (100-count units). The contract was funded by the Defense Logistics Agency (DLA), a defense agency component, and utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance of this delivery order is based in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award represents a...
- The Defense Logistics Agency awarded a $7,436.43 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Onfiant 10 mg, with delivery expected by July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical product will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,911.94 to AmerisourceBergen Drug Corp for 100 tablets of Onfivamide 10 mg, with an ultimate completion date of August 14, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH84JDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,859.99 for 100 tablets of Onfil 10 mg on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical federal medical procurement vendor through its extensive portfolio of delivery orders with the Defense Logistics Agency. The company's DLA Troop Support Medical contract enables it to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. This individual delivery order represents a routine pharmaceutical supply transaction within the larger framework of the contractor's premier vendor relationship with the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 8/19/25 |